Table 2.
Multiple linear regression models on factors affecting the IBD-SES
| Total score | Managing stress and emotions | Managing medical care | Managing symptoms and disease | Maintaining remission | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β | p-value | β | p-value | β | p-value | β | p-value | β | p-value | |
| Specialized IBD clinic/online (ref) | 0.12 | 0.018 | 0.16 | 0.002 | 0.01 | 0.817 | 0.10 | 0.041 | 0.12 | 0.017 |
| Female/male (ref) | −0.08 | 0.124 | −0.06 | 0.198 | −0.07 | 0.178 | −0.07 | 0.165 | −0.04 | 0.42 |
| Age | 0.03 | 0.625 | 0.04 | 0.518 | 0.04 | 0.52 | 0.00 | 0.988 | 0.00 | 0.945 |
| UC/CD (ref) | 0.02 | 0.751 | 0.00 | 0.976 | 0.04 | 0.463 | 0.01 | 0.877 | 0.00 | 0.989 |
| Disease duration | −0.05 | 0.345 | −0.01 | 0.88 | −0.09 | 0.114 | −0.05 | 0.374 | −0.02 | 0.725 |
| Biologics current use/no (ref) | −0.06 | 0.315 | −0.02 | 0.661 | −0.08 | 0.157 | −0.05 | 0.412 | −0.03 | 0.625 |
| Working or student/no job (ref) | 0.06 | 0.231 | 0.07 | 0.122 | 0.02 | 0.608 | 0.03 | 0.506 | 0.05 | 0.265 |
β, standardized partial regression coefficient; CD, Crohn’s disease; IBD-SES, Inflammatory Bowel Disease Self-Efficacy Scale; ref, reference category; UC, ulcerative colitis